MedPath

CIMISAN

CIMISAN

Discontinued
DIN Number

00245895

Drug Class

Human

Market Date

Dec 31, 1972

Company
HC

dr reckeweg canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00245895
AIG Number0406791001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (4)

CIMICIFUGA RACEMOSAActive
Strength: 6 X / 100 ML
Monograph: CIMICIFUGA RACEMOSA
GELSEMIUM SEMPERVIRENSActive
Strength: 4 X / 100 ML
Monograph: GELSEMIUM SEMPERVIRENS
IRIS VERSICOLORActive
Strength: 6 X / 100 ML
Monograph: IRIS VERSICOLOR
SANGUINARIA CANADENSISActive
Strength: 4 X / 100 ML
Monograph: SANGUINARIA CANADENSIS

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.